Development of AAV Variants with Human Hepatocyte Tropism and Neutralizing Antibody Escape Capacity.
Saved in:
| Title: | Development of AAV Variants with Human Hepatocyte Tropism and Neutralizing Antibody Escape Capacity. |
|---|---|
| Authors: | Pei X; Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.; Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Shao W; Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Xing A; Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Askew C; Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Chen X; Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Cui C; Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Abajas YL; Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Gerber DA; Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Merricks EP; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Nichols TC; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Li W; Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China., Samulski RJ; Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Li C; Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.; Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.; Carolina Institute for Developmental Disabilities, University of North Carolina at Chapel Hill, NC 27599, USA. |
| Source: | Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2020 Jun 03; Vol. 18, pp. 259-268. Date of Electronic Publication: 2020 Jun 03 (Print Publication: 2020). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 101624857 Publication Model: eCollection Cited Medium: Print ISSN: 2329-0501 (Print) Linking ISSN: 23290501 NLM ISO Abbreviation: Mol Ther Methods Clin Dev Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32637455 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Development of AAV Variants with Human Hepatocyte Tropism and Neutralizing Antibody Escape Capacity. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Pei+X%22">Pei X</searchLink>; Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.; Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.<br /><searchLink fieldCode="AU" term="%22Shao+W%22">Shao W</searchLink>; Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.<br /><searchLink fieldCode="AU" term="%22Xing+A%22">Xing A</searchLink>; Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.<br /><searchLink fieldCode="AU" term="%22Askew+C%22">Askew C</searchLink>; Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.<br /><searchLink fieldCode="AU" term="%22Chen+X%22">Chen X</searchLink>; Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.<br /><searchLink fieldCode="AU" term="%22Cui+C%22">Cui C</searchLink>; Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.<br /><searchLink fieldCode="AU" term="%22Abajas+YL%22">Abajas YL</searchLink>; Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.<br /><searchLink fieldCode="AU" term="%22Gerber+DA%22">Gerber DA</searchLink>; Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.<br /><searchLink fieldCode="AU" term="%22Merricks+EP%22">Merricks EP</searchLink>; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.<br /><searchLink fieldCode="AU" term="%22Nichols+TC%22">Nichols TC</searchLink>; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.<br /><searchLink fieldCode="AU" term="%22Li+W%22">Li W</searchLink>; Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.<br /><searchLink fieldCode="AU" term="%22Samulski+RJ%22">Samulski RJ</searchLink>; Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.<br /><searchLink fieldCode="AU" term="%22Li+C%22">Li C</searchLink>; Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.; Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.; Carolina Institute for Developmental Disabilities, University of North Carolina at Chapel Hill, NC 27599, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101624857%22">Molecular therapy. Methods & clinical development</searchLink> [Mol Ther Methods Clin Dev] 2020 Jun 03; Vol. 18, pp. 259-268. <i>Date of Electronic Publication: </i>2020 Jun 03 (<i>Print Publication: </i>2020). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101624857 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2329-0501 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223290501%22">23290501 </searchLink><i>NLM ISO Abbreviation: </i>Mol Ther Methods Clin Dev <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32637455 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.omtm.2020.06.003 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 259 Titles: – TitleFull: Development of AAV Variants with Human Hepatocyte Tropism and Neutralizing Antibody Escape Capacity. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Pei X – PersonEntity: Name: NameFull: Shao W – PersonEntity: Name: NameFull: Xing A – PersonEntity: Name: NameFull: Askew C – PersonEntity: Name: NameFull: Chen X – PersonEntity: Name: NameFull: Cui C – PersonEntity: Name: NameFull: Abajas YL – PersonEntity: Name: NameFull: Gerber DA – PersonEntity: Name: NameFull: Merricks EP – PersonEntity: Name: NameFull: Nichols TC – PersonEntity: Name: NameFull: Li W – PersonEntity: Name: NameFull: Samulski RJ – PersonEntity: Name: NameFull: Li C IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 06 Text: 2020 Jun 03 Type: published Y: 2020 Identifiers: – Type: issn-print Value: 2329-0501 Numbering: – Type: volume Value: 18 Titles: – TitleFull: Molecular therapy. Methods & clinical development Type: main |
| ResultId | 1 |